VC
SRRA
Vivo Capital’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-3,329,509
| Closed | -$183M | – | 54 |
|
|
2022
Q2 | $183M | Sell |
3,329,509
-2
| -0% | -$110 | 18.38% | 2 |
|
|
2022
Q1 | $107M | Buy |
3,329,511
+1,412,437
| +74% | +$45.3M | 7.35% | 5 |
|
|
2021
Q4 | $41.7M | Hold |
1,917,074
| – | – | 2.51% | 10 |
|
|
2021
Q3 | $42M | Hold |
1,917,074
| – | – | 1.89% | 12 |
|
|
2021
Q2 | $37.3M | Hold |
1,917,074
| – | – | 1.62% | 16 |
|
|
2021
Q1 | $33M | Hold |
1,917,074
| – | – | 1.16% | 20 |
|
|
2020
Q4 | $30.7M | Hold |
1,917,074
| – | – | 1.37% | 17 |
|
|
2020
Q3 | $20.5M | Hold |
1,917,074
| – | – | 1.18% | 21 |
|
|
2020
Q2 | $23.2M | Hold |
1,917,074
| – | – | 1.66% | 16 |
|
|
2020
Q1 | $18.8M | Buy |
+1,917,074
| New | +$18.8M | 1.71% | 15 |
|
|
2019
Q3 | – | Sell |
-2,438,270
| Closed | -$1.37M | – | 42 |
|
|
2019
Q2 | $1.37M | Hold |
2,438,270
| – | – | 0.13% | 42 |
|
|
2019
Q1 | $4.17M | Hold |
2,438,270
| – | – | 0.42% | 40 |
|
|
2018
Q4 | $3.22M | Hold |
2,438,270
| – | – | 0.41% | 33 |
|
|
2018
Q3 | $4.15M | Hold |
2,438,270
| – | – | 0.42% | 36 |
|
|
2018
Q2 | $7.22M | Hold |
2,438,270
| – | – | 0.93% | 25 |
|
|
2018
Q1 | $5.05M | Hold |
2,438,270
| – | – | 0.72% | 23 |
|
|
2017
Q4 | $9.1M | Hold |
2,438,270
| – | – | 1.95% | 16 |
|
|
2017
Q3 | $3.78M | Hold |
2,438,270
| – | – | 0.76% | 23 |
|
|
2017
Q2 | $2.85M | Hold |
2,438,270
| – | – | 0.72% | 20 |
|
|
2017
Q1 | $3.73M | Hold |
2,438,270
| – | – | 1.1% | 16 |
|
|
2016
Q4 | $3.63M | Hold |
2,438,270
| – | – | 1.2% | 17 |
|
|
2016
Q3 | $4.44M | Hold |
2,438,270
| – | – | 1.38% | 15 |
|
|
2016
Q2 | $4.85M | Hold |
2,438,270
| – | – | 1.33% | 15 |
|
|
2016
Q1 | $16.4M | Buy |
+2,438,270
| New | +$16.4M | 4.12% | 8 |
|